Tech Company Financing Transactions
COEPTIS Funding Round
COEPTIS, operating out of Wexford, secured $5.7 million from CJC - Crown Jewels Consultants and private investors.
Transaction Overview
Company Name
Announced On
2/6/2025
Transaction Type
Venture Equity
Amount
$5,700,000
Round
Series A
Investors
CJC - Crown Jewels Consultants (Lead Investor)
Proceeds Purpose
The proceeds from this financing will be utilized to strengthen the Company's balance sheet, repay outstanding obligations, and support general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
105 Bradford Road 420
Wexford, PA 15090
USA
Wexford, PA 15090
USA
Phone
Website
Email Address
Overview
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries including Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc. (collectively "Coeptis"), is a biopharmaceutical and technology company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases that have the potential to disrupt conventional treatment paradigms and improve patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Mehalick
Browse more venture capital transactions:
Prev: 2/6/2025: KOA Biotech venture capital transaction
Next: 2/6/2025: Mobile Pathways venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs